Zobrazeno 1 - 10
of 10
pro vyhledávání: '"329"'
Autor:
Mario Uhr, Francesco Forconi, Emanuele Zucca, Georg Stussi, Andrea Rinaldi, Francesco Bertoni, Michael Mian, Franco Cavalli, Ivo Kwee, Roberto Marasca, Gianluca Gaidano, Afua Adjeiwaa Mensah, Davide Rossi, Marco Ladetto
Publikováno v:
Blood. 120:3906-3906
Abstract 3906 The clinical course of CLL patients ranges from an indolent and chronic disease to a rapidly progressing leukemia or lymphoma necessitating aggressive treatment. Very recent data have shown that genomic complexity evaluated by conventio
Autor:
Neel Raja, Oliver C Cohen, Aoife Dervin, Max Brodermann, S Morley, Kirit M. Ardeshna, Ian Proctor, William Townsend
Publikováno v:
Blood. 134:4746-4746
Introduction Lymph node excision has historically been preferred to core biopsy in diagnosing lymphoma given reported higher diagnostic yield and concerns that core biopsies yielded insufficient material. However, core biopsy is associated with lower
Autor:
Shyamali Dutta, Prantar Chakrabarti, Prakas Kumar Mandal, Shuvra Neel Baul, Tuphan Kanti Dolai, Rajib De, Ankita Sen
Publikováno v:
Blood. 132:2348-2348
Introduction: β Haemoglobinopathy, is one of the commonest inherited disorders, with a higher prevalence in the eastern part of India. In view of the lack of facilities for allogeneic stem cell transplantation, including financial constraints, this
Autor:
Mark D. Fleming, David P. Steensma, Vilmarie Rodriguez, Shakila P. Khan, Leah A. Schmelkin, Mrinal M. Patnaik, Naseema Gangat, Matthew T. Howard, Alexandra P. Wolanskyj
Publikováno v:
Blood. 126:3355-3355
Background: Ring sideroblasts (RS) are erythroid precursors with perinuclear mitochondrial iron accumulation seen in clonal disorders, such as myelodysplastic syndromes (MDS), and non-clonal conditions, including copper deficiency, lead poisoning, an
Autor:
Kimberly B. Dahlman, Megan L. Hames, Mahsa S. Talbott, Judy P. Tsai, Wade T. Iams, Nishitha Reddy, Kristy L. Richards
Publikováno v:
Blood. 124:4438-4438
Background: The use of lenalidomide is expanding to include patients with refractory or relapsed diffuse large B cell lymphoma (DLBCL). Lenalidomide is less toxic than thalidomide, but it leads to hypothyroidism in approximately 5-10% of patients tha
Publikováno v:
Blood. 124:4856-4856
Background: Health services and outcomes research in sickle cell disease (SCD) has been limited by inadequate population-based surveillance and reliance on ICD-9 codes to identify individuals with SCD. The accuracy of ICD-9 coding in administrative c
Publikováno v:
Blood. 124:1852-1852
Background: PV is a myeloproliferative neoplasm characterized by increased red cell mass and elevated hematocrit. Phlebotomy represents the initial treatment option to lower hematocrit with the goal of reducing the risk of thrombosis. However, many p
Autor:
Georg Mann, Dieter Printz, Gertraud Fröschl, Ulrike Pötschger, Gerhard Fritsch, Michael Dworzak, Helmut Gadner, Nora Mühlegger
Publikováno v:
Blood. 99(6)
Detection of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) predicts outcome. Previous studies were invariably based on relative quantification and did not investigate sample-inherent parameters that influence test accuracy, whi
Autor:
Ajay K. Nooka, Jonathan L. Kaufman, Nishi N Shah, Bilal Hassan, Lawrence H. Boise, Ifor Williams, Sagar Lonial
Publikováno v:
Blood. 122:3148-3148
Background Heavy light chain (HLC) assays allow for accurate quantification of involved and uninvolved immunoglobulins (Ig) of the affected isotype. HLC ratio is of particular interest in measuring low level disease where there is limited utility for
Autor:
James L.M. Ferrara, Jochen Metzger, Arnold Ganser, Annika Krons, Hildegard T. Greinix, Ernst Holler, Gernot Beutel, Julia Kontsendorn, Michael Schleuning, Stefanie Buchholz, Anne M. Dickinson, N. Hahn, Hans-Jochem Kolb, Axel R. Zander, Eva Mischak-Weissinger
Publikováno v:
Blood. 114:347-347
Abstract 347 Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for many hematologic malignancies or hematopoietic dysfunction syndromes, but the application is still limited due to major complications, such as sev